Hadassah Ein Kerem

Running trials

• Active, not recruiting

  Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

  NCT06698458· Source

• Recruiting

  Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)

  NCT05657743· Source

• Recruiting

  Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

  NCT00874783· Source

• Recruiting

  Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

  NCT00801333· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ALS (motor neurone disease)2 recruiting
• Alzheimer disease1 recruiting
• Huntington's disease1 recruiting
• Macular degeneration1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Retinitis pigmentosa1 recruiting
• Spinal muscular atrophy1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· Source